Stakeholders want the US Food and Drug Administration (FDA) to narrow its scope of what it considers labeling in a draft guidance for prescription drug-use-related software (PDURS) frameworks, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results